NIKE Inc (NKE)
Mexican Exchange · Mexico · prices in MXN · close of 23 Oct 2026
Key indicators
| Last close | MXN 696.51 |
|---|---|
| 52-week range | 586.00 – 1,284.99 |
| Return, 1 month / 3 months | +11.0% / −2.0% |
| Return, 1 year / 3 years | −43.8% / −59.8% |
| Trend | Below its 200-day average |
| RSI (14) | 65 |
| Volatility (1 year) | 37.2% |
| Worst drawdown (1 year) | -50.7% |
| Average daily value traded | 3.07M MXN |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nike designs, makes and markets athletic footwear, apparel and equipment for sports and everyday wear. Its products include running, basketball and training shoes, sportswear and accessories sold under the Nike and Jordan names. The company serves athletes and general consumers through retail partners and its own stores and online channels. Nike is based in the United States, near Beaverton in Oregon, and its goods reach customers in markets around the world.
On this site NIKE Inc appears as a stock on the Mexican Exchange (Mexico), code NKE, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NIKE Inc (NKE) trades on the Mexican Exchange in Mexico. It last closed at MXN 696.51 on 23 October 2026.
Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 314 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 43.8% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 6 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.2% | ||
| From 52-week high | -45.6% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | -8.9% | ||
| 12-month return, skipping the last month | -49.4% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.7% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.07M MXN | ||
| Zero-volume days | 0.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +11.0% |
| 3 months | −2.0% |
| 6 months | −8.9% |
| 1 year | −43.8% |
| 3 years | −59.8% |
| 5 years | −76.8% |
Signals
| 50-day / 200-day average | 651.49 / 802.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 18.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | MXN 6.9518 |
| 1 Jun 2026 | MXN 7.1258 |
| 2 Mar 2026 | MXN 7.1268 |
| 1 Dec 2025 | MXN 7.4872 |
| 2 Sep 2025 | MXN 7.4950 |
| 2 Jun 2025 | MXN 7.6830 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.